BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8158213)

  • 1. Multiplicity of abnormal dystrophin in Becker muscular dystrophy. A Becker muscular dystrophy gene frequently produced two smaller sizes of dystrophin.
    Hori S; Ohtani S; Shimizu T; Ibi T; Sahashi K; Nonaka I; Miyamoto K; Tanabe H
    J Neurol Sci; 1994 Feb; 121(2):183-9. PubMed ID: 8158213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mosaic expression of two dystrophins in a boy with progressive muscular dystrophy.
    Rivier F; Tuffery S; Jellali AJ; Echenne B; Mornet D; Pons F
    Muscle Nerve; 1998 Oct; 21(10):1317-20. PubMed ID: 9736061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of dystrophin in muscular diseases by two-dimensional gel electrophoresis using agarose gels in the first dimension.
    Hamano K; Takeya T; Iwasaki N; Okoshi N; Fukubayashi T; Kirinoki M; Yao Y; Hirabayashi T; Takita H
    Acta Neurol Belg; 1996 Jun; 96(2):102-7. PubMed ID: 8711982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy.
    Arahata K; Beggs AH; Honda H; Ito S; Ishiura S; Tsukahara T; Ishiguro T; Eguchi C; Orimo S; Arikawa E
    J Neurol Sci; 1991 Feb; 101(2):148-56. PubMed ID: 2033400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunostaining of dystrophin and utrophin in skeletal muscle of dystrophinopathies.
    Sahashi K; Ibi T; Suoh H; Nakao N; Tashiro M; Marui K; Arahata K; Sugita H
    Intern Med; 1994 May; 33(5):277-83. PubMed ID: 7949630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Becker muscular dystrophy: demonstration of the carrier status of a female by immunoblotting and immunostaining.
    Chevron MP; Tuffery S; Echenne B; Demaille J; Claustres M
    Neuromuscul Disord; 1992; 2(1):47-50. PubMed ID: 1525558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dystrophin analysis in the diagnosis of childhood muscular dystrophy: an immunohistochemical study of 75 cases.
    Jay V; Becker LE; Ackerley C; Ray P
    Pediatr Pathol; 1993; 13(5):635-57. PubMed ID: 8247961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is dystrophin labelling always discontinuous in Becker muscular dystrophy?
    Slater CR; Nicholson LV
    J Neurol Sci; 1991 Feb; 101(2):187-92. PubMed ID: 2033404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy.
    Nicholson LV; Johnson MA; Gardner-Medwin D; Bhattacharya S; Harris JB
    Acta Neuropathol; 1990; 80(3):239-50. PubMed ID: 2205076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of Duchenne and Becker muscular dystrophy phenotypes with amino- and carboxy-terminal antisera specific for dystrophin.
    Bulman DE; Murphy EG; Zubrzycka-Gaarn EE; Worton RG; Ray PN
    Am J Hum Genet; 1991 Feb; 48(2):295-304. PubMed ID: 1990838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is dystrophin always altered in Becker muscular dystrophy patients?
    Vainzof M; Passos-Bueno MR; Pavanello RC; Zatz M
    J Neurol Sci; 1995 Jul; 131(1):99-104. PubMed ID: 7561956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PCR and immunoblot analyses of dystrophin in Becker muscular dystrophy.
    Uchino M; Miike T; Iwashita H; Uyama E; Yoshioka K; Sugino S; Ando M
    J Neurol Sci; 1994 Jul; 124(2):225-9. PubMed ID: 7964876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dystrophin as a diagnostic marker in Duchenne and Becker muscular dystrophy. Correlation of immunofluorescence and western blot.
    Voit T; Stuettgen P; Cremer M; Goebel HH
    Neuropediatrics; 1991 Aug; 22(3):152-62. PubMed ID: 1944822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dystrophin in skeletal muscle. II. Immunoreactivity in patients with Xp21 muscular dystrophy.
    Nicholson LV; Davison K; Johnson MA; Slater CR; Young C; Bhattacharya S; Gardner-Medwin D; Harris JB
    J Neurol Sci; 1989 Dec; 94(1-3):137-46. PubMed ID: 2693618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of dystrophin in two patients with Becker type Xp21 muscular dystrophy.
    Mongini T; Palmucci L; Doriguzzi C; Chiadoò-Piat L; Restagno G
    Neurosci Lett; 1992 Nov; 147(1):37-40. PubMed ID: 1480320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed expression of dystrophin on regenerating muscle from two siblings with Becker muscular dystrophy.
    Tachi N; Wakai S; Watanabe Y; Chiba S; Nagaoka M; Minami R
    J Neurol Sci; 1992 Jul; 110(1-2):165-8. PubMed ID: 1506856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very small dystrophin molecule in a family with a mild form of Becker dystrophy.
    Morandi L; Mora M; Bernasconi P; Mantegazza R; Gebbia M; Balestrini MR; Cornelio F
    Neuromuscul Disord; 1993 Jan; 3(1):65-70. PubMed ID: 8329891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A homologue of dystrophin is expressed at the blood vessel membrane of DMD and BMD patients: immunological evidence.
    Augier N; Boucraut J; Léger J; Anoal M; Nicholson LV; Voelkel MA; Léger JJ; Pellissier JF
    J Neurol Sci; 1992 Feb; 107(2):233-8. PubMed ID: 1564523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The frequency of patients with dystrophin abnormalities in a limb-girdle patient population.
    Arikawa E; Hoffman EP; Kaido M; Nonaka I; Sugita H; Arahata K
    Neurology; 1991 Sep; 41(9):1491-6. PubMed ID: 1842672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dystrophin-related protein in Becker muscular dystrophy.
    Higuchi I; Niiyama T; Fukunaga H; Nakamura K; Nakagawa M; Osame M
    Intern Med; 1994 Jun; 33(6):334-6. PubMed ID: 7919618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.